SPORCK ALISTAIR N
VP Contactor Business Unit
14 filings on record here, covering AEHR, LTGO, ELAN, FOA, CTNM, KR, NYSE: KRC. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-11
| Sell | AEHR | AEHR TEST SYSTEMS | $108,490 |
CORPORATEFiled 2026-08-10
| Award | LTGO | Latigo Biotherapeutics, Inc. | |
CORPORATEFiled 2026-08-10
| Award | ELAN | Elanco Animal Health Inc | $2,827 |
CORPORATEFiled 2026-08-05
| Sell | FOA | Finance of America Companies Inc. | $17,706 |
CORPORATEFiled 2026-08-03
| Exercise | CTNM | Contineum Therapeutics, Inc. | $2,525 |
| Sell | CTNM | Contineum Therapeutics, Inc. | $40,029 |
| Exercise | CTNM | Contineum Therapeutics, Inc. | |
CORPORATEFiled 2026-07-28
| Award | ELAN | Elanco Animal Health Inc | $2,827 |
CORPORATEFiled 2026-07-27
| Tax | AEHR | AEHR TEST SYSTEMS | $10,305 |
CORPORATEFiled 2026-07-14
| Award | ELAN | Elanco Animal Health Inc | $2,827 |
CORPORATEFiled 2026-07-14
CORPORATEFiled 2026-07-13
| Tax | AEHR | AEHR TEST SYSTEMS | $15,173 |
CORPORATEFiled 2026-07-10
| Award | NYSE: KRC | KILROY REALTY CORP | |
| Award | NYSE: KRC | KILROY REALTY CORP | |
CORPORATEFiled 2026-07-08
| Exercise | CTNM | Contineum Therapeutics, Inc. | $2,525 |
| Sell | CTNM | Contineum Therapeutics, Inc. | $40,000 |
| Exercise | CTNM | Contineum Therapeutics, Inc. | |
CORPORATEFiled 2026-07-02
| Award | AEHR | AEHR TEST SYSTEMS | |
| Award | AEHR | AEHR TEST SYSTEMS | |
| Tax | AEHR | AEHR TEST SYSTEMS | $186,833 |
| Tax | AEHR | AEHR TEST SYSTEMS | $18,120 |
CORPORATEFiled 2026-07-01
| Exercise | CTNM | Contineum Therapeutics, Inc. | $7,575 |
| Exercise | CTNM | Contineum Therapeutics, Inc. | $3,150 |
| Sell | CTNM | Contineum Therapeutics, Inc. | $160,080 |
| Exercise | CTNM | Contineum Therapeutics, Inc. | |
| Exercise | CTNM | Contineum Therapeutics, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.